Hypotrichosis–lymphedema–telangiectasia syndrome

From WikiMD's WELLNESSPEDIA


Hypotrichosis–lymphedema–telangiectasia syndrome
Synonyms
Pronounce N/A
Specialty N/A
Symptoms Sparse hair, lymphedema, telangiectasia
Complications
Onset
Duration
Types
Causes Genetic mutation
Risks
Diagnosis Clinical examination, genetic testing
Differential diagnosis
Prevention
Treatment Symptomatic treatment
Medication
Prognosis
Frequency
Deaths


Alternate Names[edit]

Hypotrichosis lymphedema telangiectasia syndrome; HLTS; Hypotrichosis-lymphedema-telangiectasia-membranoproliferative glomerulonephritis syndrome; Hypotrichosis-lymphedema-telangiectasia-renal defect syndrome

Definition[edit]

Hypotrichosis-lymphedema-telangiectasia syndrome (HLTS) is a rare condition that, as the name suggests, is associated with sparse hair (hypotrichosis), lymphedema, and telangiectasia, particularly on the palms of the hands.

Cause[edit]

HLTS is thought to be caused by changes (mutations) in the SOX18 gene.

Inheritance[edit]

It can follow both an autosomal dominant or an autosomal recessive pattern of inheritance, depending on the affected family.

Symptoms[edit]

For most diseases, symptoms will vary from person to person. People with the same disease may not have all the symptoms listed. 80%-99% of people have these symptoms

  • Abnormality of the lymphatic system
  • Absent eyebrow (Failure of development of eyebrows)
  • Absent eyelashes(Failure of development of eyelashes)
  • Alopecia(Hair loss)
  • Palmar telangiectasia
  • Plantar telangiectasia
  • Predominantly lower limb lymphedema
  • Sparse body hair
  • Sparse scalp hair(Reduced/lack of hair on scalp)

30%-79% of people have these symptoms

5%-29% of people have these symptoms

Treatment[edit]

There is currently no cure for the condition. Treatment is based on the signs and symptoms present in each person.

NIH genetic and rare disease info[edit]

Hypotrichosis–lymphedema–telangiectasia syndrome is a rare disease.


Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.